Uncategorized

Inovio Sinks 7% After Pricing Of $150.5M Share Offering; Street Says Hold

Shares of Inovio Pharmaceuticals dropped about 7% in Thursday’s pre-market trading after the biotech company priced its $150.5 million share offering.

Facebook’s WhatsApp Asked to Withdraw Privacy Policy By India – Report

Facebook’s WhatsApp was asked by the Indian government to withdraw the changes to its privacy policy announced earlier, Bloomberg has learnt. According to …

Steris To Buy Rival Cantel Medical For $3.6B

Steris has agreed to snap up peer Cantel Medical Corp in a cash and stock deal valued at $3.6 billion, in what marks …

Nio To Raise $1.3B From Debt Sale; Street Sees 11% Downside Risk

Nio has offered to sell an aggregate $1.3 billion in convertible senior notes as the Chinese electric vehicle company continues to tap financial …

AstraZeneca’s Heart Drug Gets FDA Nod For Stroke Reduction Use

AstraZeneca announced that the US regulator has approved its heart treatment Brilinta to be used to reduce the risk of an attack in …

Hologic Quarterly Profit Triples On Covid-19 Test Sales; Shares Rise

Hologic saw its quarterly earnings more than triple bolstered by strong demand for its COVID-19 tests, sending shares up 2.4% in Thursday’s pre-market …

Manitowoc Posts Smaller Loss Than Feared, Reinstates Guidance; Shares Jump 8%

Shares of Manitowoc Co. jumped more than 8% in Wednesday’s late trading session after the producer of construction trains posted a smaller quarterly …

Baker Hughes Snaps Up Compact Carbon Capture For Energy Transition Path

Baker Hughes announced the acquisition of Compact Carbon Capture (3C), a pioneer in carbon technology solutions, as the oil field company advances its …

SolarEdge Sinks 16% In Pre-Market On Disappointing Sales Outlook

Shares in SolarEdge Technologies Ltd. are tanking 16% in Tuesday’s pre-market trading session as the solar energy company disappointed investors with a weaker …

TFF Teams Up With Augmenta For Covid-19 Antibody Therapies; Shares Pop 7%

Shares of TFF Pharmaceuticals closed 6.5% higher on Monday as the clinical-stage biopharma company announced that it has teamed up with Augmenta Bioworks …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts